Last update 20 Mar 2025

Fazirsiran

Overview

Basic Info

Drug Type
siRNA
Synonyms
ARO-AAT, Fazirsiran Sodium
+ [3]
Target
Action
inhibitors
Mechanism
A1AT inhibitors(Alpha-1-antiproteinase inhibitors), RNA interference
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationFast Track (United States), Orphan Drug (European Union), Breakthrough Therapy (United States)
Login to view timeline

Structure/Sequence

Boost your research with our RNA technology data.
Boost your research with our RNA technology data.

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CicatrixPhase 3
Portugal
06 Mar 2023
CicatrixPhase 3
Czechia
06 Mar 2023
CicatrixPhase 3
Switzerland
06 Mar 2023
CicatrixPhase 3
Australia
06 Mar 2023
CicatrixPhase 3
Poland
06 Mar 2023
CicatrixPhase 3
Brazil
06 Mar 2023
CicatrixPhase 3
Belgium
06 Mar 2023
CicatrixPhase 3
Sweden
06 Mar 2023
CicatrixPhase 3
Italy
06 Mar 2023
Alpha 1-Antitrypsin DeficiencyPhase 3
United States
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
16
(100 mg)
(tanaokrmdt) = psvbnvsutn egeqfqrskt (bdrytcpfdn )
Positive
26 Jun 2021
(200 mg)
(tanaokrmdt) = scevbqikuo egeqfqrskt (bdrytcpfdn )
Phase 2
9
ayfwttgojz(shwkirwigp) = bvbfiozlll atxebmybqc (iztlenibul )
-
23 Jun 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free